BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

52 hedge funds and large institutions have $16.9M invested in BRAINSTORM CELL THERAPUTC in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 24 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
24
Closed
10
Calls
$3.84M
Puts
$3.62M
Net Calls
+$222K
Net Calls Change
+$419K

Top Buyers

1
SM
1
Sabby Management
Florida
$1.57M
2
GCP
2
GSA Capital Partners
United Kingdom
$568K
3
PVI
3
Pura Vida Investments
New York
$353K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$129K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.73M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$1.47M
2
Millennium Management
2
Millennium Management
New York
$496K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$118K
4
TEE
4
Tibra Equities Europe
United Kingdom
$0
5
First Trust Advisors
5
First Trust Advisors
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
First Trust Advisors
51
First Trust Advisors
Illinois
– -$284K -4,979 Closed
Renaissance Technologies
52
Renaissance Technologies
New York
– -$181K -3,173 Closed
ECM
53
ExodusPoint Capital Management
New York
– -$48K -846 Closed
Jane Street
54
Jane Street
New York
– -$48K -836 Closed
ASN
55
Advisory Services Network
Georgia
– -$45K -787 Closed
LP
56
LMR Partners
United Kingdom
– -$45K -782 Closed
Citigroup
57
Citigroup
New York
– -$10K -183 Closed
CCMW
58
Cypress Capital Management (Wyoming)
Wyoming
– -$4K -67 Closed
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
– -$1K -18 Closed
1 2
3